HALO
Halozyme Therapeutics, Inc.
NASDAQHealthcareBiotechnologyUS
USD77.18
+2.22 (+2.96%)
Rating:B+
Company Profile
CEO
Helen I. Torley
IPO Date
2004-03-16
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$75.28
Prev. Close
$74.96
Day Low
$74.47
Day High
$77.24
52W Low
$51.06
52W High
$82.22
Market Cap
$9.15B
Volume
2.08M